Cited by

• Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.

  Prendergast EN, Holzapfel M, Mueller JJ, Leitao MM Jr, Gunderson CC, Moore KN, Erickson BK, Leath CA 3rd, Diaz Moore ES, Cohen JG, Walsh CS. Prendergast EN, et al. Gynecol Oncol. 2017 Feb;144(2):274-278. doi: 10.1016/j.ygyno.2016.12.004. Epub 2016 Dec 12. Gynecol Oncol. 2017. PMID: 27979319 Free PMC article.
• Establishment and characterization of a clear cell carcinoma cell line, designated NOCC, derived from human ovary.

  Ohyama A, Toyomura J, Tachibana T, Isonishi S, Takahashi H, Ishikawa H. Ohyama A, et al. Hum Cell. 2016 Oct;29(4):188-96. doi: 10.1007/s13577-016-0142-x. Epub 2016 Aug 19. Hum Cell. 2016. PMID: 27541369
• Ultrastructure of clear cell carcinoma of the ovary. Case report and review of the literature.

  Genton CY. Genton CY. Virchows Arch A Pathol Anat Histol. 1979 Dec;385(1):77-91. doi: 10.1007/BF00433543. Virchows Arch A Pathol Anat Histol. 1979. PMID: 162102
• Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.

  Itamochi H, Kato M, Nishimura M, Oumi N, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Nonaka M, Kudoh A, Terakawa N, Kigawa J, Harada T. Itamochi H, et al. Hum Cell. 2013 Sep;26(3):121-7. doi: 10.1007/s13577-013-0062-y. Epub 2013 Feb 21. Hum Cell. 2013. PMID: 23430509
• Ovarian clear cell adenocarcinoma: a continuing enigma.

  Tan DS, Kaye S. Tan DS, et al. J Clin Pathol. 2007 Apr;60(4):355-60. doi: 10.1136/jcp.2006.040030. Epub 2006 Oct 3. J Clin Pathol. 2007. PMID: 17018684 Free PMC article. Review.